Aandelen in “Diensten aan de gezondheidssector”

Aandeel Datum Koers Evolutie
vlag Equasens 30/04 58,900 EUR
-0,67% 		-0,67%
vlag Eurofins Scientific S.E. 30/04 57,600 EUR
-1,87% 		-1,87%

Nieuws over “Diensten aan de gezondheidssector”

1/05 · Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI · Persbericht

1/05 · Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI · Persbericht

30/04 · Cegedim: INCREASE OF MEANS OF THE LIQUIDITY CONTRACT · Persbericht

29/04 · Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. · Persbericht

29/04 · Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B · Persbericht

25/04 · Cegedim achieves solid growth in first quarter 2024 · Persbericht

25/04 · Labcorp Announces 2024 First Quarter Results · Persbericht

25/04 · Labcorp Announces Winning Bid for Select Assets of Invitae · Persbericht

25/04 · Invitae Enters into Agreement with Labcorp for Sale of Business · Persbericht

24/04 · Bedrijfsnieuws uit Amerika · Bolero.be

Pepsico boekte 1% hogere omzet bij lagere volumes Het drankenbedrijf boekte een omzetgroei van 1% bij een daling van de volumes. Pepsico verdiende 1,61 dollar per aandeel , hoger dan de gemiddelde analistenverwachtingen...

23/04 · Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 · Persbericht

22/04 · Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease · Persbericht

15/04 · Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw · Persbericht

12/04 · Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting · Persbericht

11/04 · Labcorp Declares Quarterly Dividend · Persbericht

10/04 · Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit · Persbericht

8/04 · Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) · Persbericht

8/04 · Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs · Persbericht

5/04 · Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research · Persbericht

4/04 · Cegedim: Release of its 2023 Universal Registration Document · Persbericht

2/04 · Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay · Persbericht

Mijn selecties